China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., commonly referred to as Sanjiu, is a leading player in the pharmaceutical industry, headquartered in China. Established in 1992, the company has made significant strides in the healthcare sector, focusing on the research, development, and manufacturing of traditional Chinese medicine and modern pharmaceuticals. With a strong operational presence across various regions in China, Sanjiu is renowned for its diverse portfolio of core products, including herbal medicines, over-the-counter drugs, and health supplements. The company’s commitment to innovation and quality has positioned it as a trusted name in the market, achieving notable milestones such as extensive research collaborations and a robust distribution network. Sanjiu's dedication to enhancing public health through effective and accessible healthcare solutions underscores its prominent market position, making it a key contributor to the pharmaceutical landscape in China and beyond.
How does China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s score of 22 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., headquartered in CN, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to set measurable targets for reducing carbon emissions. As the sector evolves, it is likely that China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. will develop and disclose its climate strategies and emissions data in the future.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.